Stay updated with breaking news from Novel Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
01.02.2024 - Signs a World-Wide Exclusive License with Stony Brook University for a Novel Platform that can Enhance Radionuclide TargetingReceives up to $2.4M NIH Grant to Develop Differentiated Antibody-based Radiopharmaceutical Approach SEATTLE, Feb. 01, ... Seite 1
Signs a World-Wide Exclusive License with Stony Brook University for a Novel Platform that can Enhance Radionuclide TargetingReceives up to $2.4M ...
/PRNewswire/ -- SK Biopharmaceuticals, a global biotech focused on the research, development and commercialization of treatments for disorders of the central...
SK Biopharmaceuticals, a global biotech focused on the research, development and commercialization of treatments for disorders of the central nervous system (CNS) and oncology, and its U.S. R&D subsidiary, Proteovant Therapeutics, today announced...
/PRNewswire/ -- Caris Life Sciences®(Caris), the leading molecular science, artificial intelligence (AI) and machine learning technology company actively...